UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

(Mark One)

x QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2011

OR

¨ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________

COMMISSION FILE NUMBER 333-143761

3DICON CORPORATION
(Exact Name of small business issuer as specified in its charter)
 
Oklahoma
 
73-1479206
(State or other jurisdiction of
 
(I.R.S. Employer
incorporation or organization)
 
Identification No.)

6804 South Canton Avenue, Suite 150, Tulsa, Oklahoma 74136
(Address of principal executive offices) (Zip Code)

Issuer's Telephone Number: (918) 494-0505

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x   No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x   No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
Large accelerated filer ¨
Accelerated filer ¨
Non-accelerated filer ¨ (do
not check if smaller reporting
company)
Smaller reporting company
x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨   No x

As of August 10, 2011, the issuer had 1,154,988,693 outstanding shares of Common Stock.

 
 

 

TABLE OF CONTENTS

   
Page
 
PART I – Financial Information
 
Item 1.
Financial Statements.
F-1
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations.
3
Item 3.
Quantitative and Qualitative Disclosures About Market Risk.
8
Item 4.
Controls and Procedures.
8
 
PART II – Other Information
 
Item 1.
Legal Proceedings.
8
Item 1A.
Risk Factors.
8
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
8
Item 3.
Defaults Upon Senior Securities.
9
Item 4.
(Removed and Reserved).
9
Item 5.
Other Information.
9
Item 6.
Exhibits.
9
SIGNATURES
10
 
 
2

 

PART I

Item 1.    Financial Statements.
 


INDEX TO FINANCIAL STATEMENTS

 
Page
Balance Sheets as of June 30, 2011 (Unaudited) and December 31, 2010 (Audited)
F-2
   
Statements of Operations for the three and six months ended June 30, 2011 and 2010 and period from inception (January 1, 2001) to June 30, 2011 (Unaudited)
F-3
   
Statements of Changes in Stockholders' Deficiency for period from inception (January 1, 2001) to June 30, 2011 (Unaudited)
F-4
   
Statements of Cash Flows for the six  months ended June 30, 2011 and 2010 and  period from inception (January 1, 2001) to June 30, 2011 (Unaudited)
F-5
   
Notes to Financial Statements
F-6
 
 
F-1

 

3DIcon CORPORATION
(A Development Stage Company)
BALANCE SHEETS
June 30, 2011 and December 31, 2010
   
June 30,
   
December 31,
 
   
2011
   
2010
 
   
(Unaudited)
   
(Audited)
 
Assets
           
Current assets:
           
Cash
  $ 572,186     $ 367,101  
Prepaid expenses
    31,435       21,771  
Accounts receivable
    22,850       7,092  
Total current assets
    626,471       395,964  
                 
Net property and equipment
    11,958       15,709  
Deposits-other
    2,315       2,315  
Total Assets
  $ 640,744     $ 413,988  
                 
Liabilities and Stockholders' Deficiency
               
Current liabilities:
               
Current maturities of convertible debentures payable
  $ 164,804     $ 403,445  
Warrant exercise advances
    164,782       -  
Accounts payable
    253,308       203,590  
Accrued salaries
    -       501,362  
Accrued interest on debentures
    -       41,174  
Total current liabilities
    582,894       1,149,571  
                 
Convertible promissory notes, 5%, due 2013
    -       400,878  
Accrued interest due 2013
    -       4,120  
Long term debt
    -       404,998  
                 
Total Liabilities
    582,894       1,554,569  
                 
Common stock subject to put rights and call right, 59,000,000 shares
    485,649       485,649  
                 
Stockholders' deficiency:
               
Common stock $.0002 par, 1,500,000,000 shares authorized; 1,090,726,578 and 757,539,307 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively
    218,145       151,508  
Additional paid-in capital
    14,400,379       12,322,913  
Deficit accumulated during development stage
    (15,046,323 )     (14,100,651 )
Total Stockholders' Deficiency
    (427,799 )     (1,626,230 )
Total Liabilities and Stockholders' Deficiency
  $ 640,744     $ 413,988  
 
See notes to financial statements

 
F-2

 

3DIcon CORPORATION
(A Development Stage Company)
STATEMENTS OF OPERATIONS
Three and Six Months Ended June 30, 2011 and 2010
and Period from Inception (January 1, 2001) to June 30, 2011
(Unaudited)

   
Three Months
   
Three Months
   
Six Months
   
Six Months
       
   
Ended
   
Ended
   
Ended
   
Ended
   
Inception to
 
   
June 30, 2011
   
June 30, 2010
   
June 30, 2011
   
June 30, 2010
   
June 30, 2011
 
Income:
                             
License fee
  $ -     $ -     $ -     $ -     $ 25,000  
Sales
    -       4,300       3,000       4,300       40,797  
Grant income
    24,889       18,487       54,889       28,765       186,390  
                                         
Total income
    24,889       22,787       57,889       33,065       252,187  
                                         
Expenses:
                                       
Research and development
    183,193       246,090       283,627       320,059       3,499,627  
General and administrative
    426,112       303,029       686,933       536,485       11,368,227  
Interest
    4,647       16,607       33,001       37,298       430,656  
                                         
Total expenses
    613,952       565,726       1,003,561       893,842       15,298,510  
                                         
Net loss
  $ (589,063 )   $ (542,939 )   $ (945,672 ) )   $ (860,777 )   $ (15,046,323 )
                                         
Loss per share:
                                       
basic and diluted
  $ (0.001 )   $ (0.001 )   $ (0.001 )   $ (0.002 )        
                                         
Weighted average shares outstanding, basic and diluted
    1,102,198,888       466,963,229       996,509,835       426,166,215          

See notes to financial statements

 
F-3

 

3DIcon CORPORATION
(A Development Stage Company)
STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIENCY
Period from Inception (January 1, 2001) to June 30, 2011
(Unaudited)

                     
Deficit
       
                     
Accumulated
       
   
Common Stock
   
Additional
   
During the
       
         
Par
   
Paid-In
   
Development
       
   
Shares
   
Value
   
Capital
   
Stage
   
Total
 
Balance, January 1, 2001 – as reorganized
    27,723,750     $ 27,724     $ 193,488     $ -     $ 221,212  
                                         
Accrued stock compensation earned but unissued
    -       -       -       (60,000 )     (60,000 )
Stock issued for services
    2,681,310       2,681       185,450       -       188,131  
Stock issued for cash
    728,500       729       72,121       -       72,850  
Net loss for the year
    -       -       -       (259,221 )     (259,221 )
Balance, December 31, 2001
    31,133,560       31,134       451,059       (319,221 )     162,972  
                                         
Accrued stock compensation earned but unissued
    -       -       -       (60,000 )     (60,000 )
Stock issued for services
    3,077,000       3,077       126,371       -       129,448  
Stock issued for cash
    1,479,000       1,479       146,421       -       147,900  
Net loss for the year
    -       -       -       (267,887 )     (267,887 )
Balance, December 31, 2002
    35,689,560       35,690       723,851       (647,108 )     112,433  
                                         
Accrued stock compensation earned but unissued
    -       -       -       (90,000 )     (90,000 )
Stock issued for services
    15,347,000       15,347       -       -       15,347  
Stock issued for cash
    1,380,000       1,380       33,620       -       35,000  
Reverse split 1:10
    (47,174,904 )     -       -       -       -  
Par value $0.0001 to $0.0002
    -       (51,369 )     51,369       -       -  
Net loss for the year
    -       -       -       (51,851 )     (51,851 )
Balance, December 31, 2003
    5,241,656       1,048       808,840       (788,959 )     20,929  
                                         
Additional founders shares issued
    25,000,000       5,000       (5,000 )     -       -  
Stock issued for services
    24,036,000       4,807       71,682       -       76,489  
Stock issued for cash
    360,000       72       28,736       -       28,808  
Warrants issued to purchase common stock at $.025
    -       -       18,900       -       18,900  
Warrants issued to purchase common stock at $.05
    -       -       42,292       -       42,292  
Stock warrants exercised
    2,100,000       420       60,580       -       61,000  
Net loss for the year
    -       -       -       (617,875 )     (617,875 )
Balance, December 31, 2004
    56,737,656       11,347       1,026,030       (1,406,834 )     (369,457 )
                                         
Stock issued for services
    5,850,000       1,170       25,201       -       26,371  
Stock issued to settle liabilities
    5,000,000       1,000       99,000       -       100,000  
Stock issued for cash
    1,100,000       220       72,080       -       72,300  
Warrants issued to purchase common stock at $.025
    -       -       62,300       -       62,300  
Warrants issued to purchase common stock at $.05
    -       -       140,400       -       140,400  
Stock warrants exercised
    5,260,000       1,052       172,948       -       174,000  
Net loss for the year
    -       -       -       (592,811 )     (592,811 )
Balance, December 31, 2005
    73,947,656       14,789       1,597,959       (1,999,645 )     (386,897 )
                                         
Stock issued for services
    4,700,000       940       205,597       -       206,537  
Debentures converted
    3,000,000       600       149,400       -       150,000  
Stock issued for cash
    200,000       40       16,160       -       16,200  
Warrants issued to purchase common stock
    -       -       33,800       -       33,800  
Warrants converted to purchase common stock
    16,489,000       3,297       565,203       -       568,500  
Net loss for the year
    -       -       -       (1,469,888 )     (1,469,888 )
Balance, December 31, 2006
    98,327,656       19,666       2,568,119       (3,469,533 )     (881,748 )
                                         
Stock issued for services
    817,727       164       155,262       -       155,426  
Stock issued for interest
    767,026       153       38,198       -       38,351  
Stock based compensation
    -       -       1,274,666       -       1,274,666  
Debentures converted
    17,215,200       3,442       1,673,741       -       1,677,183  
Stock issued for cash
    1,188,960       238       191,898       -       192,136  
Options exercised
    222,707       45       (45 )     -       -  
Warrants issued to purchase common stock
    -       -       87,864       -       87,864  
Warrants converted to purchase common stock
    8,585,956       1,717       462,203       -       463,920  
Net loss for the year
    -       -       -       (3,928,996 )     (3,928,996 )
Balance, December 31, 2007
    127,125,232       25,425       6,451,906       (7,398,529 )     (921,198 )
                                         
Stock issued for cash
    515,677       103       24,897       -       25,000  
Warrants exercised
    1,347,261       269       362,425       -       362,694  
Stock based compensation
    -       -       654,199       -       654,199  
Debentures converted
    15,257,163       3,052       962,257       -       965,309  
Options exercised and escrowed shares
    8,671,460       1,734       (1,734 )     -       -  
Stocks issued for service
    4,598,973       920       312,880       -       313,800  
Net loss for the year
    -       -       -       (3,611,550 )     (3,611,550 )
Balance, December 31, 2008
    157,515,766       31,503       8,766,830       (11,010,079 )     (2,211,746 )
                                         
Stock issued for cash
    20,607,841       4,122       197,878       -       202,000  
Warrants exercised
    35,100       7       382,583       -       382,590  
Debentures converted
    77,451,141       15,490       467,514       -       483,004  
Stocks issued for service
    68,506,130       13,701       524,653       -       538,354  
Stock issued for accounts payable
    11,264,706       2,253       321,409       -       323,662  
Stock issued for interest
    8,310,128       1,662       41,647       -       43,309  
Warrants issued for accounts payable
    -       -       13,505       -       13,505  
Net loss for the year
    -       -       -       (1,566,835 )     (1,566,835 )
Balance, December 31, 2009
    343,690,812       68,738       10,716,019       (12,576,914 )     (1,792,157 )
                                         
Stock issued for cash
    5,714,286       1,143       8,857       -       10,000  
Warrants exercised
    47,523       9       517,991       -       518,000  
Debentures converted
    255,650,977       51,130       228,061       -       279,191  
Stock issued for services
    97,684,416       19,538       213,348       -       232,886  
Stock issued for liabilities
    48,657,897       9,732       204,682       -       214,414  
Stock issued for interest
    6,093,396       1,218       15,843       -       17,061  
Stock based compensation
    -       -       418,112       -       418,112  
Net loss for the year
    -       -       -       (1,523,737 )     (1,523,737 )
Balance, December 31, 2010
    757,539,307       151,508       12,322,913       (14,100,651 )     (1,626,230 )
                                         
Warrants and options exercised
    3,923,962       784       607,815       -       608,599  
Debentures converted
    223,248,851       44,650       607,537       -       652,187  
Stock issued for services
    5,700,000       1,140       110,098       -       111,238  
Stock issued for liabilities
    97,530,393       19,506       536,521       -       556,027  
Stock issued for interest
    7,094,511       1,419       41,533       -       42,952  
Escrowed shares cancelled
    (4,310,446 )     (862 )     862       -       -  
Stock-based compensation
    -       -       173,100               173,100  
Net loss for the period
    -       -       -       (945,672 )     (945,672 )
Balance, June 30, 2011
    1,090,726,578     $ 218,145     $ 14,400,379       (15,046,323 )   $ (427,799 )

See notes to financial statements

 
F-4

 

3Dicon CORPORATION
(A Development Stage Company)
STATEMENTS OF CASH FLOWS
Six Months ended June 30, 2011 and 2010
and Period from Inception (January 1, 2001) to June 30, 2011
(Unaudited)

   
Six Months
   
Six Months
   
Inception to
 
   
Ended June 30,
   
Ended June 30,
   
June 30,
 
   
2011
   
2010
   
2011
 
Cash Flows from Operating Activities
                 
Net loss
  $ (945,672 )   $ (860,777 )   $ (15,046,323 )
Adjustments to reconcile net loss to net cash used in operating activities:
                       
Options issued for services
    173,100       -       2,520,078  
Stock issued for services
    111,238       293,113       1,994,028  
Stock issued for interest
    42,952       113,025       141,673  
Book value of assets retired
    668       -       6,529  
Amortization of debt issuance costs
    -       16,706       170,414  
Depreciation
    3,083       3,083       24,044  
Impairment of assets
    -       -       292,202  
                         
Change in:
                       
Prepaid expenses and other assets
    (25,422 )     (42,100 )     (305,000 )
Accounts payable and accrued liabilities
    75,138       275,149       2,019,339  
                         
Net cash used in operating activities
    (564,915 )     (201,801 )     (8,183,339 )
                         
Cash Flows from Investing Activities
                       
Purchase of office furniture and equipment
    -       -       (42,531 )
Net cash used in investing activities
    -       -       (42,531 )
                         
Cash Flows from Financing Activities
                       
Proceeds from stock and warrant sales, exercise of warrants, options and warrant exercise advances
    770,000       202,240       4,488,455  
Proceeds from issuance of debentures and notes
    -       -       4,309,591  
                         
Net cash provided by financing activities
    770,000       202,240       8,798,046  
                         
Net increase in cash
    205,085       439       572,176  
Cash, beginning of period
    367,101       1,118       10  
                         
Cash, end of year
  $ 572,186     $ 1,557     $ 572,186  
                         
Supplemental Disclosures
                       
Non-Cash Investing and Financing Activities
                       
Conversion of debentures to common stock (net)
  $ 652,187     $ 13,553     $ 4,206,321  
Cash paid for interest
  $ 5,245     $ -     $ 293,735  
Stock issued to satisfy payables
  $ 556,027     $ 159,141     $ 1,987,253  
Debenture issued to satisfy payable
  $ -     $ -     $ 125,909  
Stock issued subject to put rights and call right to satisfy payables
  $ -     $ -     $ 485,649  

See notes to financial statements

 
F-5

 

3Dicon CORPORATION
(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS
(Unaudited)

Note 1 – Uncertainties and Use of Estimates
 
Basis of Presentation
 
The accompanying financial statements of 3DIcon Corporation (the “Company”) have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations. The Company believes that the disclosures made are adequate to make the information presented not misleading. These financial statements should be read in conjunction with the Company's year-end audited financial statements and related footnotes included in the previously filed 10-K. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position of the Company as of June 30, 2011, and the statements of its operations for the three and six months ended June 30, 2011 and 2010, and the period from inception (January 1, 2001) to June 30, 2011, and cash flows for the six month periods ended June 30, 2011 and 2010, and the period from inception (January 1, 2001) to June 30, 2011, have been included. The results of operations for interim periods may not be indicative of the results which may be realized for the full year.
 
Use of Estimates
 
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and the disclosure of contingent assets and liabilities. Actual results could differ from the estimates and assumptions used.
 
Revenue Recognition
 
Revenues from software license fees are accounted for in accordance with Accounting Standards Codification (“ASC”) 985-605, “Software Revenue Recognition”.  The Company recognizes revenue when (i) persuasive evidence of an arrangement exists; (ii) delivery has occurred or services have been rendered; (iii) the sales price is fixed or determinable; and (iv) collectability is reasonably assured.
 
Grant revenue is recognized when earned.
 
Recent Accounting Pronouncements
 
Based on management's assessment no new accounting standards, if adopted, would have a material impact on the accompanying financial statements.
 
Uncertainties
 
The accompanying financial statements have been prepared on a going concern basis.  The Company is in the development stage and has insufficient revenue and capital commitments to fund the development of its planned product and to pay operating expenses.
 
The Company has realized a cumulative net loss of $15,046,323 for the period from inception (January 1, 2001) to June 30, 2011, and a net loss of $945,672 and $860,777 for the six months ended June 30, 2011 and 2010, respectively.
 
The ability of the Company to continue as a going concern during the next year depends on the successful completion of the Company's capital raising efforts to fund the development of its planned products.  The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 
F-6

 
 
Management plans to fund the future operations of the Company with existing cash, grants and investor funding. Under the terms of the Golden State debentures, as further described in Note 4, Golden State may advance an additional $378,787.  The additional advance would be available if the Company filed a registration statement; however, the Company does not plan to file such registration statement. In addition, pursuant to the 4.75% Convertible Debenture due in November 2011, beginning in November 2007, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year.  In connection with each conversion, Golden State is expected to exercise warrants equal to ten times the amount of principal converted.  The warrants are exercisable at $10.90 per share.  The number of warrants exercisable is subject to certain beneficial ownership limitations contained in the 4.75% Convertible Debenture (“the Beneficial Ownership Limitations”).  The Beneficial Ownership Limitations prevent Golden State from converting on the 4.75% Convertible Debenture or exercising warrants if such conversion or exercise would cause Golden State’s holdings to exceed 9.99% of the Company’s issued and outstanding common stock.  Subject to the Beneficial Ownership Limitations, Golden State is required to convert $3,000 of the 4.75% Convertible Debenture and exercise 30,000 warrants per month.  Based upon our current stock price, our issued and outstanding shares as of June 30, 2011 and ignoring the impact of the Beneficial Ownership Limitations, the Company may receive up to $1,962,000 in funding from Golden State as a result of warrant exercises during the remainder of the year ended December 31, 2011. During the six months ended June 30, 2011, the Company received $753,382 in funding under the terms of the 4.75% Convertible Debenture (see Note 4).
 
The Company was approved for a matching grant from Oklahoma Center for the Advancement of Science and Technology (“OCAST”) on November 19, 2008 in the amount of approximately $300,000.  There remains $113,610 of grant funds to be provided during 2011.  (see Note 3)
 
Additionally, the Company is continuing to pursue financing through private offering of debt or common stock.
 
Note 2 – Sponsored Research Agreement ("SRA") Common Stock Subject to Put Rights and Call Right
 
On April 20, 2004, the Company entered into a Sponsored Research Agreement entitled "Investigation of Emerging Digital Holography Technologies" ("Phase I") with the University of Oklahoma (the “University” or “OU”), which expired October 19, 2004. The Company paid the University $14,116 pursuant to this agreement. The purpose of this agreement was to conduct a pilot study to investigate digital holography as a candidate technology for the development of three-dimensional ("3D") imaging and visualization systems and to investigate the current state-of-the-art research and development activities taking place in the field of digital holography, particularly emerging technologies. The scope of work for the study encompassed the following tasks:
 
 
·
Literature review to determine key leading edge research in relevant areas;
 
 
·
Review of related commercial products to identify technological approaches and potential competitors and/or partners;
 
 
·
Preliminary patent review; and
 
 
·
Recommendations for product research and development directions.
 
On July 15, 2005, the Company entered into a Sponsored Research Agreement (“Phase II”) with the University, which expired on January 14, 2007. Under this agreement, the University conducted a research project entitled "Investigation of 3-Dimensional Display Technologies" and the Company agreed to pay the University $453,584 at various dates from November 10, 2005 through July 15, 2006 to cover the costs of the research. The goals for this research were as follows:
 
 
·
Produce patentable and/or copyrightable intellectual property;
 
 
·
Produce proof-of-concept technology that demonstrates the viability of the intellectual property;
 
 
·
Assess opportunities for manufacturing technological products in Oklahoma;
 
 
·
Investigate magnetic nanospheres (“MNs”) for use as a projection media;
 
 
·
Develop a control platform to actively distribute MNs in an unbounded volumetric space;
 
 
·
Investigate the doping of MNs with fluorescent materials for light emission at different wavelengths, i.e., develop fluorescent MNs ("FMNs");
 
 
·
Evaluate other display medium technologies for potential strategic partnerships;
 
 
·
Evaluate the most appropriate (from a cost-to-benefit standpoint) solid-state light sources for projection applications;
 
 
·
Develop software for displaying ideal 3D images; and
 
 
·
Investigate software interface issues with other image capture technologies.
 
 
F-7

 
 
The final payment of $226,792, due on July 15, 2006, was not paid. On November 1, 2006 the SRA was modified to provide $125,259 additional funding, extend the term of the agreement through March 31, 2007, and revise the payment schedule to combine the July 15, 2006 remaining balance due of $226,792 with the additional funding into a revised payment schedule. Under the terms of the agreement, the Company agreed to pay the combined remaining obligation of $352,051 in four equal monthly installments of $88,013 beginning on December 31, 2006 through March 31, 2007.
 
On February 23, 2007, the Company entered into a SRA with the University ("Phase III") which expired on March 31, 2010. Under this agreement, the University conducted a research project entitled "3-Dimensional Display Development".  The Company agreed to pay the University $3,468,595 in monthly installments ranging from $92,263 to $112,777 beginning on April 30, 2007 and ending on March 31, 2010.
 
On October 31, 2008, OU agreed to revise the payment terms under the SRA from a fixed monthly payment to a reimbursable cost payment basis effective September 1, 2008. As of September 30, 2008 the Company had a remaining obligation under the previous SRA payment schedule of $2,665,818 which included monthly payments due for December 2007 through August 31, 2008 of $861,131. The $1,804,687 balance of the remaining scheduled payment obligation was cancelled. Under the terms of the revised base payments schedule, the arrearages were to be paid in nine monthly base installments from October 31, 2008 to June 30, 2009 of amounts ranging from $35,000 to $101,132 leaving a remaining balance after the base payments of $290,000. In addition to the monthly base payments, the Company agreed to make additional payments on the $861,131 arrearages based on a formula of 50% of funding in excess of $120,000 plus the base monthly payment. In the event funding did not provide for any additional payments, the remaining balance would be $290,000, which OU agreed to accept 4,264,707 shares of our common stock based on the October 14, 2008 market price as reported on the OTC Bulletin Board of $0.068 per share as payment on June 30, 2009. The Company had the option to repurchase the shares at $0.068 per share by September 30, 2009 or at market value, but not less than $0.068 per share, if the repurchase occured after September 30, 2009.
 
On February 19, 2010, OU agreed to modify the repayment plan to retire the remaining arrearages outstanding of $525,481. Under the terms of the modified repayment plan the Company agreed to make payments to the University, not less than quarterly, in an amount equal to 22.5% of any funding received by the Company.  The first quarterly payment was due to the University on April 30, 2010.  These repayment terms were to remain in effect until the outstanding debt was retired.
 
On December 1, 2010, the Company entered into an agreement (the "Agreement") with OU pursuant to which OU agreed to convert all sums due to it from the Company in connection with its SRA with the Company, which as of December 1, 2010 amounted to approximately $485,000, into an aggregate of 59,000,000 shares ("OU 3DIcon Equity") of the Company's common stock (the "Shares"). As a result of the debt conversion, OU became the holder of approximately 8% of the outstanding common stock of the Company. Pursuant to the Agreement, the Shares are subject to a put option allowing OU to require the Company to purchase certain of the Shares upon the occurrence of certain events. In addition, the Shares are subject to a call option allowing the Company to require OU to sell to the Company the Shares then held by OU in accordance with the terms of the Agreement as follows:
 
OU Put Right - If, at any time during the one-year period beginning on the second anniversary of the Effective Date (the "OU Put 1 Period"), the sum of:  (a) the value [stock price times number of shares] of the OU 3DIcon Equity held by OU at such time, plus (b) the proceeds (if any) of prior sales by OU of the OU 3DIcon Equity is less than $100,000, OU shall have the right to put (require 3DIcon or, at 3DIcon's option, another buyer, to redeem or purchase) one tenth (1/10) of the shares described herein for $50,000 plus 7% thereon annually from the Effective Date, less the amount (if any) of proceeds from the sale by OU of OU 3DIcon Equity (the "OU Put 1 Right"). If at any time during the one-year period beginning on the third anniversary of the Effective Date (the "OU Put 2 Period"), the sum of:  (a) the value [stock price times number of shares] of the OU 3DIcon Equity held by OU at such time, plus (b) the proceeds (if any) of prior sales by OU of the OU 3DIcon Equity, including those put according to OU Put 1 Right and if such put occurred, is less than $970,000, OU shall have the right to put (require 3DIcon or, at 3DIcon's option, another buyer, to redeem) the shares for $485,000 plus 7% thereon annually from the Effective Date, less the amount (if any) of proceeds from the sale by OU of OU 3DIcon Equity (the "OU Put 2 Right"). The OU Put 2 right will be exercisable at any time during the OU Put 2 Period in which the trading price for 3DIcon stock has remained at or less than a trading price such that the sum of the amounts specified in clauses (a) and (b) above is exceeded by $970,000 less the proceeds of sales (if any) by OU of OU 3DIcon Equity for (i) ten consecutive trading days or (ii) twenty of thirty consecutive trading days. If OU puts the stock to 3DIcon as outlined above and OU does not receive the amount due within a 90-day period following a notification period, 3DIcon would be in default under any and all of the OU-3DIcon Agreements.
 
3DIcon Call Right - At any time during the one-year period following the third anniversary of the Effective Date, 3DIcon shall have the right to call (require OU to sell to 3DIcon) the OU 3DIcon Equity then held by OU for an amount equal to $970,000 less the amount (if any) of the proceeds of prior sales by OU of the OU 3DIcon Equity (the "3DIcon Call Right"). Provided, however, OU shall not be required to pay 3DIcon any amounts it receives as a result of prior sales of the 3DIcon Equity. In the event that 3DIcon elects to exercise the 3DIcon Call Right, 3DIcon will provide OU's Norman Campus Vice-President for Research, General Counsel, and Vice-President for Technology Development with a one hundred twenty day written notice of such intent. Any sales by OU of OU 3DIcon Equity shares during such one hundred twenty day period will not be subject to the 3DIcon Call Right.

 
F-8

 

The Company has presented the shares outside of stockholders’ deficiency in the mezzanine section of the balance sheets, as the Agreement includes put rights, which are not solely within the control of the Company.
 
The Agreement also amended the existing agreements between the Company and OU such that all intellectual property, including all inventions and or discoveries, patentable or un-patentable, developed before July 28, 2008 by OU under the SRA is owned by OU. All intellectual property, including all inventions and/or discoveries, patentable or un-patentable, developed jointly by the Company and OU at any time is jointly owned by the Company and OU. Finally, all intellectual property developed by the Company after July 28, 2008, including all inventions and or discoveries, patentable or un-patentable, is owned by the Company.
 
During the six month periods ended June 30, 2011 and 2010, the Company charged operations $14,028 and $26,043, respectively, pursuant to the SRA.
 
Note 3 – OCAST Grant
 
The Oklahoma Center for the Advancement of Science and Technology approved the Company’s application for funding of a matching grant titled 800 Million Voxels Volumetric Display, on November 19, 2008.  The two-year matching grant, totaling $299,932, had a start date of January 1, 2009.  The Company received approval for our no cost extension request for the first year of the contract. With the new modification, the first year ended on August 31, 2010.  The award is for a maximum of $149,940 for 2009 and the remainder for 2011.  The Company earned $54,889 and $28,765 from the grant during the six-month periods ended June 30, 2011 and 2010, and $186,390 inception to date.  The Company received approval for our no cost extension request for the second year of the contract and, with the new modification, the second year ends on August 31, 2011.
 
Note 4 – Debentures Payable
 
Debentures payable consist of the following:
 
   
June 30,
2011
   
December 31,
2010
 
Senior Convertible Debentures:
           
6.25% Debenture due 2011
  $ 81,788     $ 189,120  
4.75% Debenture due 2011
    83,016       88,416  
13.0% Debenture due 2011
    -       100,703  
13.0% Debenture due 2011
    -       25,206  
Total Debentures
    164,804       403,445  
Less - Current Maturities
    (164,804 )     (403,445 )
Long-term Debentures
  $ -     $ -  
 
6.25% Convertible Debenture due December 31, 2011
 
On November 21, 2007, the Company issued and sold a convertible note in the principal amount of $1,250,000 (the “Debenture”) to Golden State Equity Investors, Inc. f/k/a Golden Gate Investors (“Golden Gate”). Pursuant to the terms of the Debenture, Golden State may, at its election, convert all or a part of the Debenture into shares of the Company's common stock at a conversion rate equal to the lesser of (i) $2.00 or (ii) 90% of the average of the five lowest volume weighted average prices during the twenty trading days prior to Golden State's election to convert, subject to adjustment as provided in the Debenture. In addition, pursuant to the terms of the Debenture, the Company agreed to file a registration statement covering the shares of common stock issuable upon conversion or redemption of the Debenture. The Company filed a registration statement covering the shares to be issued upon conversion of the Debenture. Included in the registration statement were 4.25 million shares issuable on the Debenture based on 2007 market prices and assuming full conversion of the convertible debenture. The registration statement became effective on January 4, 2008.

 
F-9

 
 
Golden State advanced $125,000 on the $1.25 million Debenture on November 9, 2007 and $746,213 in January 2008 at which time the Company placed 7,961,783 shares of common stock in escrow to be released as debentures are converted. As of September 30, 2010, Golden State has funded an aggregate of $871,213 on the Debenture. Golden State will be obligated to fund the Company for the remaining $378,787 in principal on the Debenture upon the effectiveness of a registration statement underlying the remaining unfunded principal balance on the Debenture. At this time, the Company has not filed a registration statement. At various dates during 2009, $115,043, of the Debenture was converted into 12,124,828 shares of common stock at prices ranging from $0.007 to $0.01 based on the formula in the convertible debenture. At various dates during 2010, $274,438 of the Debenture was converted into 93,196,578 shares of common stock at prices ranging from $0.0027 to $0.004 based on the formula in the convertible debenture. Shares totaling 6,093,396 were issued in payment of $17,062 of accrued interest during 2010. At various dates during 2011, $120,000 of the Debenture was converted into 9,124,055 shares of common stock at prices ranging from $0.006 to $0.017 based on the formula in the convertible debenture. Additionally $12,669 of accrued interest due through March 15, 2011 was added to the debenture balance during the six month period ended June 30, 2011. The 4,310,446 shares remaining in escrow and reported as outstanding at December 31, 2010 were cancelled in the first quarter of 2011.
 
The conversion price for the $1.25 million Debenture is the lesser of (i) $2.00 or (ii) 90% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion.  If Golden State elects to convert a portion of the debenture and, on the day that the election is made, the volume weighted average price is below $0.75, the Company shall have the right to prepay that portion of the debenture that Golden State elected to convert, plus any accrued and unpaid interest, at 135% of such amount.
 
In addition to standard default provisions concerning timeliness of payments, delivery and notifications, the Second Debenture will be in default if the common stock of the Company trades at a price per share of $0.21 or lower, regardless of whether the trading price subsequently is higher than $0.21 per share. The trading price was at $0.21 or lower on several occasions during and subsequent to the period ended June 30, 2011. On each of the occasions Golden State, by separate letter agreements, agreed that the occasions did not constitute a default and thereby waived the default provision for those occasions only.  (see Note 10 - Subsequent Events)
 
4.75% Convertible Debenture due November 3, 2011
 
On November 3, 2006, the Company also issued to Golden State a 4.75% convertible debenture in a principal amount of $100,000, due 2011, and warrants to buy 1,000,000 shares of the common stock at an exercise price of $10.90 per share. Under the terms of the debenture, warrants are exercised in an amount equal to ten times the dollar amount of the debenture conversion. During 2009, Golden State converted $3,510 of the $100,000 debenture into 35,622,803 shares of common stock, exercised warrants to purchase 35,100 shares of common stock at $10.90 per share and the Company received $382,590 from the exercise of the warrants. During 2009, Golden State advanced $240,000 against future exercises of warrants and applied $4,181 of accrued interest due on the debenture to the advance account of which $336,170 was applied to the exercise of warrants leaving $48,511 of unapplied advances at December 31, 2009. During 2010, Golden State converted $4,752 of the $100,000 debenture into 162,454,399 shares of common stock, exercised warrants to purchase 47,523 shares of common stock at $10.90 per share and advanced $251,489 against future exercises of warrants of which $300,000 was applied to the exercise of warrants leaving $-0- of unapplied advances at December 31, 2010. During 2011, Golden State converted $5,400 of the $100,000 debenture into 38,615,468 shares of common stock, exercised warrants to purchase 54,000 shares of common stock at $10.90 per share and applied $3,382 of accrued interest and advanced $750,000 against future exercises of warrants of which $588,589 was applied to the exercise of warrants leaving $164,782 of unapplied advances at June 30, 2011.
 
The conversion price for the 4.75% $100,000 convertible debenture is the lesser of (i) $4.00 or (ii) 80% of the average of the five lowest volume weighted average prices during the twenty (20) trading days prior to the conversion. If Golden State elects to convert a portion of the debenture and, on the day that the election is made, the volume weighted average price is below $0.75, the Company shall have the right to prepay that portion of the debenture that Golden State elected to convert, plus any accrued and unpaid interest, at 135% of such amount.
 
Newton, O'Connor, Turner & Ketchum 10% Convertible Debentures
 
On May 22, 2009, the Company issued to Newton, O'Connor, Turner & Ketchum, a professional corporation ("NOTK") and the legal counsel to the Company through 2008, a 10% convertible debenture in a principal amount of $100,703, due September 30, 2009, and warrants to purchase 4,378,394 shares of the common stock at an exercise price of $0.09 per share through September 30, 2010 and an exercise price of $0.18 per share through September 30, 2014. The Company was indebted to NOTK for legal services performed for the Company and reimbursement of expenses in rendition of those services for the period ended December 31, 2008. The debenture and the warrants were issued in settlement of the indebtedness. The debentures and warrants were recorded at their pro rata fair values in relation to the proceeds received. The warrants were valued at $13,504. The difference between the pro rata fair value and face value of the debenture was charged to operations in 2009. The interest rate on the debenture increased to 13% during 2009 due to the Company not making payments when due.

 
F-10

 
 
The estimated fair value of the warrants was determined using the Black-Scholes option pricing model. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 160.73% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 2.23% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the warrant of two years is based on historical exercise behavior and expected future experience.
 
On March 1, 2010, Newton, O'Connor, Turner & Ketchum agreed to extend the September 30, 2009 due date of their 13% debenture to March 31, 2010, in consideration for one million (1,000,000) shares of common stock. The shares, which are restricted under SEC Section 144, were valued at 50% of the average of the previous five day closing price on March 1, 2010, which was $0.002 per share totaling $4,140.
 
On June 1, 2010, Newton, O'Connor, Turner & Ketchum agreed to extend the March 31, 2010 due date of their 13% debenture to September 30, 2010 in consideration for one million five hundred thousand (1,500,000) shares of common stock and a reduction in the exercise price of the warrants. The revised price at which the warrant may be exercised shall be $0.045 per share for exercises made during the period between the date of grant and the second anniversary of the revised maturity date, and $0.09 per share for exercises made during the forty-eight month period between the second anniversary of the revised maturity date and the sixth anniversary of the maturity date. The shares, which are restricted under SEC Section 144, were valued at 50% of the average of the previous five day closing price on June 1, 2010, which was $0.004 per share totaling $6,210.
 
On March 31, 2011, Newton, O'Connor, Turner & Ketchum agreed to extend the September 30, 2010 due date of their 13% debenture to April 30, 2011 in consideration for two hundred thousand (200,000) shares of common stock and an extension of the exercise dates of the warrants. The revised dates at which the warrant may be exercised shall be $0.045 per share for exercises made during the period between the date of grant and the second anniversary of the revised maturity date, and $0.09 per share for exercises made during the forty-eight month period between the second anniversary of the revised maturity date and the sixth anniversary of the revised maturity date. The shares, which are restricted under SEC Section 144, were valued at 50% of the average of the previous five day closing price on March 31, 2011, which was $0.07 per share totaling $14,048.
 
On June 2, 2010, the Company issued to NOTK a second 10% convertible debenture in a principal amount of $25,206, due September 30, 2010, and warrants to purchase 3,360,847 shares of the common stock at an exercise price of $0.045 per share through September 30, 2012 and an exercise price of $0.09 per share through September 30, 2016. The Company was indebted to NOTK for legal services performed for the Company and reimbursement of expenses in rendition of those services for the period ended December 31, 2009. The debenture and the warrants were issued in settlement of the indebtedness.  The interest rate on the debenture increased to 13% during 2010 due to the Company not making payments when due.
 
On April 30, 2011, Newton, O'Connor, Turner & Ketchum agreed to convert their 13% convertible debentures and accrued interest, which totaled in the aggregate $159,842 into 18,972,186 common shares of the Company’s common stock, at an average price per share of $0.008, under the terms of the convertible debentures. The shares are restricted under SEC Section 144.
 
Note 5 – Convertible Promissory Notes 5%, Due 2013
 
In October 2010, the Company issued 5% Convertible Promissory Notes (the “Notes”) to six persons, in the aggregate, totaling $400,877. The Notes mature three years from the date issued. The Notes automatically convert to common stock of the Company at $0.0034 per share (the "Fixed Conversion Price") prior to March 15, 2011, upon the merger or consolidation of the Company with or into another person, the Company effects any sale of all or substantially all of its assets, any tender or exchange offer of the Company's common stock, or the Company effectively converts into or exchanges the Company's common stock for other securities, cash or property. Additionally, after March 15, 2011, at the option of the holder, the Notes are convertible into common stock of the Company at a price per share of $0.0025 (75% of the "Fixed Conversion Price"). Interest on the Notes accrue from the original issue date at 5% annually, is payable upon maturity or conversion of the Notes and such interest may be converted in whole or part to shares of common stock at the effective conversion price.
 
At various dates during 2011, the six persons converted the $400,877 Notes and accrued interest of $9,020 into 163,631,653 shares of common stock at $0.0025 per share.  The shares are restricted under SEC Section 144.

 
F-11

 

Note 6 – Common Stock and Paid-In Capital
 
On November 19, 2010 the Board of Directors of the Company authorized an amendment to the Company's Certificate of Incorporation in order to (i) increase the authorized shares of the Company's common stock from 750,000,000 shares, par value $0.0002 to 1,500,000,000 shares, par value $0.0002, (ii) effect a reverse split of the Company's common stock in a ratio in the range between 1 for 10 and 1 for 25, as will be selected by the Company's Board of Directors (the "Reverse Split"), and (ii) create a series of "blank check" preferred stock consisting of 25,000,000 shares, par value $0.0002.   On May 16, 2011, the Company announced that the Company’s Board of Directors elected to allow its authorization to effect a reverse stock split to expire on June 1, 2011.
 
Warrants issued
 
Pursuant to Subscription Agreements entered into during March and April 2009, the Company sold 999,999 shares of the Company's common stock at a per share price of $0.03 per share and warrants to purchase 500,000 shares of its common stock at a price of $0.10 per share from closing for a period of twelve months; $0.15 per share for the second subsequent twelve months; or $0.20 per share for the subsequent twelve months to three accredited individuals. The Company received $30,000 in cash from the sale. The 500,000 warrants are valued at $6,579 and the 999,999 shares are valued at $23,421. The warrants terminate three years from date of issue in 2012.
 
The estimated fair value of the warrants was determined using the Black-Scholes option pricing model. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 178% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.38% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience.
 
Pursuant to Subscription Agreements entered into during October and November 2009, the Company sold 1,666,666 shares of the Company's common stock at a per share price of $0.03 per share and warrants to purchase 16,666,666 shares of its common stock at a price of $0.10 per share from closing for a period of twelve months; $0.25 per share for the second subsequent twelve months and; $0.50 per share for the third subsequent twelve months to two accredited individuals. The Company received $50,000 in cash from the sale. The 16,666,666 warrants are valued at $35,225 and the 1,666,666 shares are valued at $14,775. The warrants terminate three years from date of issue in 2012.
 
 The estimated fair value of the options was determined using the Black-Scholes option pricing model. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 178% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.38% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience.
 
As of June 30, 2011, there are warrants outstanding to purchase, 500,000 shares of common stock at a price of $0.20 per share that expire on various dates in March and April 2012, warrants to purchase 16,666,666 shares of its common stock at a price of $0.10 per share through 2012 at $0.25 per share through 2011 and $0.50 per share through 2012, warrants to purchase 4,378,394 shares of common stock at a price of $0.045 per share through April 30, 2012 and $0.09 per share that expire on April 30, 2016 and, warrants to purchase 3,360,847 shares of common stock at a price of  $0.09 per share that expire on June 1, 2015. Additionally, Golden State has warrants outstanding to purchase 830,160 shares of common stock at a price of $10.90 per share which expire December 31, 2011.
 
Common stock and options issued for services and liabilities
 
The law firm of Newton, O’Connor, Turner & Ketchum was issued shares totaling 200,000 on March 31, 2011, in consideration of extending the due date of the 13% convertible debenture due September 30, 2010 to April 30, 2011.
 
Effective as of May 17, 2011, the Directors of the Company granted 1,977,900 options to each of the three Directors, Martin Keating, John O'Connor and Victor Keen, totaling 5,933,700 options, to purchase Rule 144 common stock of the Company for the exercise price of $.04 per share during the ten year period from June 1, 2011 though May 31, 2021 (the "Options"); the exercise price is based upon the average of the closing price of the stock for the five trading days before the date of the Board Consent; the fair market value of each Option is $0.038; one-half of the Options vest on the date granted and the remaining one-half of the Options shall vest on December 31, 2011.  The options are for services the Directors have provided and are providing to the Company for calendar year 2011.
  
The estimated fair value of the options of $225,000, was determined using the Black-Scholes option pricing model.  One half of the value, $112,500, was charged to operation in May 2011. The remaining one-half, $112,500, will be charged to operation during the third and fourth quarters of 2011.  The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 172% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.87% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience.

 
F-12

 

On June 13, 2011, the Company entered into a one (1) year Agreement for At-Will Employment with Assignment of Inventions (“Employment Agreement”) with Sidney A. Aroesty, pursuant to which Mr. Aroesty began serving as the Company’s Chief Executive Officer, effective June 13, 2011.  Under the terms of the Employment Agreement, Mr. Aroesty is entitled to an annual base salary of $120,000 and, at the discretion of the Company’s Board of Directors (the “Board”), performance-based bonuses and/or salary increases.  Pursuant to the Employment Agreement, the Company granted Mr. Aroesty five-year stock options to purchase two (2) million shares at a price equal to the average price of the five day period prior to June 13, 2011 (the “Strike Price”).  Furthermore, if Mr. Aroesty remains employed by the Company, he will receive additional stock options to purchase three (3) million shares at the Strike Price upon the completion of a trade show prototype that displays the Company’s technology.
 
The Employment Agreement contains provisions for non-disclosure of confidential information pursuant to which Mr. Aroesty agreed to refrain from using or disclosing to third parties, directly or indirectly, any Confidential Information, as defined in the Employment Agreement, either during or following his employment with the Company.  Furthermore, Mr. Aroesty unconditionally and irrevocably assigned any now-existing or later-created Invention(s), as defined in the Employment Agreement, which are developed during or three (3) years after his employment with the Company.
 
The Employment Agreement may be terminated with or without reason by either the Company or Mr. Aroesty and at any time, upon sixty (60) days written notice.  The terms of the Employment Agreement will remain effective for one (1) year and will automatically renew, subject to the same termination rights.  Upon termination, the Company will pay any base pay, bonus and benefits that have been earned and are due as of the date of the termination.
 
The estimated fair value of the two million options of $60,600, was determined using the Black-Scholes option pricing model and was charged to operation in June 2011. The expected dividend yield of $-0- is based on the average annual dividend yield as of the grant date. Expected volatility of 172% is based on the historical volatility of the stock since July 25, 2007, the day the Company began trading on the Over-The-Counter Bulletin Board. The risk-free interest rate of 1.43% is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option of five years is based on historical exercise behavior and expected future experience.
 
During the six-month periods ended June 30, 2011 and 2010, shares of common stock totaling 5,700,000 and 48,000,164, respectively were issued for consulting services for which the Company recognized $111,238 and $113,025 of expense, respectively.  Additionally, during the period ending June 30, 2011 and 2010, shares totaling 40,530,393 and 44,452,387, respectively were issued to consultants for previous services provided to the Company for which the accounts payable liability was reduced by $95,621 and $159,141, respectively.  Shares totaling 57,000,000, which are restricted under SEC Section 144, were issued in the first quarter of 2011 in payment of accrued salaries and payroll taxes totaling $460,405 due Martin Keating, Chairman of the Board of Directors, Hakki Refai, Chief Technology Officer and Judith Keating the Secretary of the Company.  The Company received $20,000 and after withholding the related income taxes, shares of common stock totaling 3,869,962 were issued upon the exercise of four million options under the terms of the employment agreement with Dr. Hakki Refai.
 
The following summary reflects warrant and option activity for the six-month period ended June 30, 2011:
 
  
 
Attached
Warrants
   
Golden State
Warrants
   
Options
 
                   
Outstanding December 31, 2010
    24,905,908       884,160       71,065,995  
Granted
    -       -       14,933,700  
Exercised
    -       (54,000 )     (4,000,000 )
Cancelled
    -       -       (5,000,000 )
                         
Outstanding June 30, 2011
    24,905,908       830,160       76,899,695  

 
F-13

 
 
Stock options are valued at the date of award, which does not precede the approval date, and compensation cost is recognized in the period the options are granted. Stock options generally become exercisable on the date of grant and expire based on the terms of each grant.
 
The estimated fair value of options for common stock granted was determined using the Black-Scholes option pricing model. The expected dividend yield is based on the average annual dividend yield as of the grant date. Expected volatility is based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option is based on historical exercise behavior and expected future experience.
 
Note 7 – Incentive Stock Plan
 
In February 2010 the Company established the 3DIcon Corporation 2010 Incentive Stock Plan (the "2010 Plan"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2010 Plan shall not exceed seventy-five million (75,000,000) shares. The shares are included in a registration statement filed February 26, 2010. Shares totaling 71,910,973 were issued from the 2010 Plan during the period ended December 31, 2010 for services rendered and to satisfy accounts payable to the Company. Shares totaling 3,089,027 were issued from the 2010 Plan during the period ended June 30, 2011 for services rendered and to satisfy accounts payable to the Company. There are no shares available for issuance under the 2010 Plan.
 
In June 2010 the Company established the 3DIcon Corporation 2010 Equity Incentive Stock Plan (the "2010 EIP"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2010 EIP shall not exceed sixty million (60,000,000) shares.  The shares are included in a registration statement filed June 24, 2010. Shares totaling 58,509,328 were issued from the 2010 EIP during the period ended December 31, 2010 for services rendered and to satisfy accounts payable to the Company. Shares totaling 1,490,672 were issued from the 2010 EIP during the period ended June 30, 2011 for services rendered and to satisfy accounts payable to the Company.  There are no shares available for issuance under the 2010 EIP.
 
In January 2011 the Company established the 3DIcon Corporation 2011 Equity Incentive Stock Plan (the "2011 EIP"). The total number of shares of stock which may be purchased or granted directly by options, stock awards or restricted stock purchase offers, or purchased indirectly through exercise of options granted under the 2011 EIP shall not exceed one hundred million (100,000,000) shares.  The shares are included in a registration statement filed January 14, 2011. Shares totaling 43,700,694 were issued from the 2011 EIP during the period ended June 30, 2011 for services rendered and to satisfy accounts payable to the Company. There are currently 56,299,306 shares available for issuance under the 2011 EIP.
 
Note 8 – Office Lease
 
The Company signed an Office Lease Agreement (the “Lease Agreement”) on April 24, 2008. The Lease Agreement commenced on June 1, 2008 and expired June 1, 2011. On March 8, 2011 the Lease Agreement was amended to extend the expiration date to May 31, 2012.  At June 30, 2011, minimum future lease payments to be paid annually under the non-cancelable operating lease for office space are as follows:
 
2011
  $ 13,888  
2012
  $ 11,573  
Total
  $ 25,461  
 
 
F-14

 
 
Note 9 – Related Party Transaction
 
3DIcon has engaged the law firm of Newton, O’Connor, Turner & Ketchum as its outside corporate counsel since 2005. John O’Connor, a director of 3DIcon, is the Chairman of Newton, O’Connor, Turner & Ketchum.   During the periods ended June 30, 2011 and 2010, the Company incurred legal fees to Newton, O’Connor, Turner & Ketchum in the amount of $41,463 and $7,568 respectively.
 
Note 10 – Subsequent Events
 
Debentures payable
 
In accordance with the terms of the Second Debenture an event of default occurs if the common stock of the Company trades at a price per share of $0.21 or lower. The trading price was at $0.21 or lower on several occasions during the period ended June 30, 2011 and subsequent to June 30, 2011.  On each of the occasions Golden State, by letter agreements, agreed that the occasions did not constitute a default and thereby waived the default provision for the occasions.
 
Common stock issued for services and liabilities
 
Subsequent to June 30, 2011 shares of common stock totaling 5,262,115 were issued for consulting services for which the Company recognized $48,265 of expense. Shares totaling 5,262,115 were issued to consultant for previous services provided to the Company for which the accounts payable liability was reduced by $48,265.

 
F-15

 
 
Item 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

The information in this report contains forward-looking statements. All statements other than statements of historical fact made in this report are forward looking. In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements. These forward-looking statements can be identified by the use of words such as “believes,” “estimates,” “could,” “possibly,” “probably,” anticipates,” “projects,” “expects,” “may,” “will,” or “should” or other variations or similar words. No assurances can be given that the future results anticipated by the forward-looking statements will be achieved. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Our actual results may differ significantly from management’s expectations.

The following discussion and analysis should be read in conjunction with our financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.

Plan of Operation

Background:

The Company is engaged in the development of 360° volumetric imaging and display technology, specifically in the areas identified by the initial in-depth investigation conducted by the University. The identified areas are two major complementary areas of technology that comprise the spectrum of the solution and application (1) a means of recording 3D objects as digital data elements (capture); and (2) a means of reconstructing and displaying the 3D images (display).

Based on the investigation as well as review of existing patents and technologies, it was concluded that the area of 3-D image capture and recording had multiple solutions and technologies that adequately served the market. Therefore our primary area of focus is to develop products and intellectual property in the reconstruction and display of 3D images where we see the most opportunity. We aim to establish strategic partnerships with the assignees or license holders of existing 3D recording technologies as well as integrate our technologies with existing solutions.

The existing products reviewed can generally be broken down into two broad categories: stereoscopic - those that use flat-panels to implement 3D displays on 2D screens, and those that implement volumetric 3D displays. The flat-panel approaches, as previously noted, do not support 3DIcon's planned embodiment of the technology. However, the application space of volumetric 3D displays supports the Company vision and appears to offer major opportunities for further technology development and creation of intellectual property through our staff and the University, to which 3DIcon will have exclusive rights.

The research team at OU has been working to integrate open source image capture applications as well as to establish 3D image capture systems.

We continue to build intellectual property through our staff and the University, to which the Company has exclusive rights and engage in product research and development both directly related to the display as well as by-product technologies.

The Oklahoma Center for the Advancement of Science and Technology approved the Company’s application for funding of a matching grant titled 800 Million Voxels Volumetric Display, on November 19, 2008.  The two-year matching grant, totaling $299,932, had a start date of January 1, 2009.  The Company received approval for our no cost extension request for the first year of the contract. With the first modification, the first year ended on August 31, 2010.  The award was for a maximum of $149,940 for 2009 and the remainder for 2010.  The Company earned $54,889 and $28,765 from the grant during the periods ended June 30, 2011 and 2010, and $186,390 from inception to date.  The Company received approval for our no cost extension request for the second year of the contract. With the new modification, the second year ends on August 31, 2011.

Current Activities and Operations

The Company is pursuing the research and development of volumetric 3-D display technology through the SRA with the University and with Dr. Hakki Refai, the former chief researcher at the University, who joined the Company as our Chief Technology Officer in October 2008.  Our efforts are focused on multiple technological approaches, one of which is being further developed into proof-of-concept demonstration systems.

 
3

 

Static Volume Display Technology: Also known as CSpace®™, the Company has produced the first non-mechanical, multi-view, high-resolution volumetric display. A prototype was demonstrated during September 2008, when a 3D image was created within a proprietary volumetric media (also called projection space or image matrix). This technology incorporates existing and rapidly evolving image projection technologies, such as DLP®/DMD technology from Texas Instruments, allowing 3DIcon to pursue full-color, full-motion 3D visualization, in harmony with 3DIcon's vision for product development.

We have also released a software product called Pixel Precision™. The current version of the software is 2.0 that was released on February 12, 2009 to expand its capabilities and provide new compatibility with Texas Instrument's newly released DLP® Discovery 4000 kits. We plan to continue to pursue this market and provide versions and variations of this software. The plans include enhancements to the functionality as well as variants to address additional opportunities.

We have signed a sales and distribution agreement with Digital Light Innovations (“DLi”) for the sales, marketing and first level support of the Pixel Precision™ software. Through DLi and its sub-distributors the software will be marketed in the United States as well as in Europe and Asia.

Progress on Research and Development Activities

Under the aegis of the SRA, the University has filed the following patent applications. The utility patents have been converted and consolidated from the previously filed provisional applications.

Description of
Provisional Patent
Application as Filed
 
Description of Utility
Patent Application
Filing (Combined)
 
Date of Filing
 
Granted
U.S. Patent
 
European
Pending
Patent-
Date of
Filing
 
Japanese
Pending
Patent-Date of
Filing
Swept Volume Display
 
Swept Volume Display
 
Filed by OU in September 2006
           
                     
Colorful Translation Light Surface 3D Display Colorful Translation 3D Volumetric Display 3D Light Surface Display
 
Light Surface Display for Rendering Three-Dimensional Image (Combined)
 
Filed by OU in April 2007
 
December 28, 2010
 
April 2007
 
April 2007
                     
Volumetric Liquid Crystal Display
 
Volumetric Liquid Crystal Display for Rendering Three-Dimensional Image (Combined)
 
Filed by OU in April 2007
 
May 2009
       
                     
Computer System Interaction with DMD
 
Computer System Interaction with DMD
 
Filed by OU in January 2008
           
                     
Virtual Moving Screen for Rendering Three Dimensional Image
 
Virtual moving screen for rendering a three-dimensional image
 
Filed by OU in January 2008
           
                     
Optically Controlled Light Emitting and System for Optically Written 2D and 3D Displays
 
Utility Patent Application to be filed
 
Filed by 3DIcon in April 2008
           

Further, we are taking steps to explore areas that may be related to assist in the protection of intellectual property assets. In addition, we have begun the process of applying for trademarks related to our 3D technologies.

The primary objective for 2011 is to develop, and produce a prototype, CSpace single-color video display, in the form of a dome or alternately-shaped transparent enclosure not less than 8” in diameter, which can be viewed without operational safety controls (e.g., goggles), in moderately-bright room lighting, uniformly over 360° and from the top.  The prototype display will satisfy the requirements of ISO 9241-303 for single-color direct-view displays.  The associated research and development objectives for the 2011 calendar year are as follows. The work will be done by the Company and professional consultants:

I. Static Volumetric Display (“CSpace®™”)

 
·
Continue work on development of up-conversion materials.
 
·
Synthesize non-toxic, non-flammable liquid media suitable for dispersion of display materials.
 
·
Develop optical, thermal, and packaging designs for the prototype.
 
·
Continue software development to enhance CSpace®™ with the capability of displaying near real time 3D images.

 
4

 

II. By-Product Technologies

 
·
Continue to generate revenue from Pixel Precision™ the DMD Control Software for DMD Application development markets.

RESULTS OF OPERATIONS FOR THE THREE MONTHS ENDED JUNE 30, 2011 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2010

Revenue

The Company earned $18,487 and $24,889 from the OCAST grant during the three months ended June 30, 2011 and 2010, respectivetly.

We have earned income of $-0- and $4,300 before commissions and costs from the sales of Pixel Precision™ for the three-months ended June 30, 2011 and June 30, 2010, respectively.

We expect sales of Pixel Precision™ to the installed and active user base of the earlier D1100 and D3000 systems in the near term and as companion product sales to D4000 systems. We expect that the revenue from this product to contribute to the operating expenses (general and administrative, research and development, interest) but do not expect the revenue generated in 2011 to cover the operating expenses.

Research and Development Expenses

The research and development expenses were $183,193 for the three months ended June 30, 2011, as compared to $246,090 for the three months ended June 30, 2010.  The decrease was a result of options issued in 2010 to Hakki Refai valued at approximately $168,000 and a $6,000 decrease in cost incurred with the University under the SRA.  We also had increases in 2011 of $76,000 for expenses incurred for the purchase of lab supplies and equipment consultants and $32,000 for the CSpace®™ prototype development consulting contract with Advanced Optical Technologies.

General and Administrative Expenses

Our general and administrative expenses were $426,112 for the three months ended June 30, 2011 as compared to $303,029 for the three months ended June 30, 2010.  The increase is due primarily to consultants $86,500, auditing fees $12,500, travel $22,500, and the salary of and options issued to the new CEO of $ 70,600.

Interest Expense

Interest expense for the three months ended June 30, 2011 was $4,647 as compared to $16,607 for the three months ended June 30, 2010.  The decrease was a result of the decrease in the amounts outstanding on our convertible debentures and the conversion of the Newton, O'Connor, Turner & Ketchum 13% Convertible Debentures to common stock.

RESULTS OF OPERATIONS FOR THE SIX MONTHS ENDED JUNE 30, 2011 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2010

Revenue

The Company received $54,889 from the OCAST grant during the six months ended June 30, 2011 as compared to $28,765 for the six months ended June, 2010.  The increase was due to additional expenditures under the grant.

There were sales of $3,000 of PixelPrecision™ during the six months ended June 30, 2011 as compared to $4,300 for the six months ended June 30, 2010.

We expect sales of Pixel Precision™ to the installed and active user base of the earlier D1100 and D3000 systems in the near term and as companion product sales to D4000 systems.  We expect that the revenue from this product to contribute to the operating expenses (general and administrative, research and development, interest) but do not expect the revenue generated to cover the operating expenses.

Research and Development Expenses

Research and development expenses were $283,627 for the six months ended June 30, 2011, as compared to $320,059 for the six months ended June 30, 2010.   The net decrease was a result of the cost of vesting of options to the Director of Technology in 2010 amounting to $168,000 and an increase in expenses incurred for lab supplies and equipment $29,000 and consultants engaged amounting to $109,000 in 2011.

 
5

 

General and Administrative Expenses

Our general and administrative expenses were $686,933 for the six months ended June 30, 2011 as compared to $536,485 for the six months ended June 30, 2010.  The increase was the result of the increase in legal fees of $45,000 and the increase in cost related to the hiring of and options issued to the new CEO and consultants of approximately $100,000.

Interest Expense

Interest expense for the six months ended June 30, 2011 was $33,001 as compared to $37,298 for the six months ended June 30, 2010. The change in interest expense resulted from decreases in the amounts outstanding on our convertible debentures during the periods.

Financial Condition, Liquidity and Capital Resources

Management remains focused on controlling cash expenses. We recognize our limited cash resources and plan our expenses accordingly. We intend to leverage stock-for-services wherever possible. The operating budget consists of the following expenses:

 
·
Research and development expenses pursuant to our SRA with the University. This includes development of an initial demonstrable prototype and a second prototype for static volume technology.
 
·
Acceleration of research and development through increased research personnel as well as other research agencies.
 
·
General and administrative expenses: salaries, insurance, investor related expenses, rent, travel, website, etc.
 
·
Hiring executive officers for technology, operations and finance.
 
·
Development, support and operational costs related to Pixel Precision™ software.
 
·
Professional fees for accounting and audit; legal services for securities and financing; patent research and protection.

Our independent registered public accountants, in their audit report accompanying our financial statements for the year ended December 31, 2010, expressed substantial doubt about our ability to continue as a going concern due to our status as a development stage organization with insufficient revenues to fund development and operating expenses.

We had net cash of $572,186 at June 30, 2011.

We had positive working capital of $43,577 at June 30, 2011.

During the six months ended June 30, 2011, we used $564,915 of cash for operating activities, an increase of $363,114 or 180% compared to the six months ended June 30, 2010. The increase in the use of cash for operating activities was a result of the increase in the net loss of approximately $85,000, the decrease in stock issued for interest of approximately $57,000 and a decrease in the change in accounts payable of approximately $213,000.

There was no cash used in investing activities during the six months ended June 30, 2011 or  2010.

Cash provided by financing activities during the six months ended June 30, 2011 was $770,000, an increase of $567,760 or 266% compared to the six months ended June 30, 2010.  The increase was the result of warrant exercise advances from Golden State and options exercised.

We expect to fund the ongoing operations through the existing financing in place (see below); and; through raising additional funds as permitted by the terms of Golden State financing.

Our ability to fund the operations of the Company is highly dependent on the underlying stock price of the Company.

Pursuant to the 4.75% Convertible Debenture due in 2011, beginning in November 2007, Golden State is obligated to submit conversion notices in an amount such that Golden State receives 1% of the outstanding shares of the Company every calendar quarter for a period of one year. In connection with each conversion, Golden State is expected to exercise warrants equal to 10 times the amount of principal converted. The warrants are exercisable at $10.90 per share. Beginning in November 2008, Golden State is required to convert $3,000 of the 4.75% Convertible Debenture and exercise 30,000 warrants per month. During 2009, Golden State converted $3,510 of the $100,000 debenture into 35,622,803 shares of common stock, exercised warrants to purchase 35,100 shares of common stock at $10.90 per share and the Company received $382,590 from the exercise of the warrants. During 2009, Golden State advanced $240,000 against future exercises of warrants and applied $4,181 of accrued interest due on the debenture to the advance account of which $336,170 was applied to the exercise of warrants leaving $48,511 of unapplied advances at December 31, 2009. During 2010, Golden State converted $4,752 of the $100,000 debenture into 162,454,399 shares of common stock, exercised warrants to purchase 47,523 shares of common stock at $10.90 per share and advanced $251,489 against future exercises of warrants of which $300,000 was applied to the exercise of warrants leaving $-0- of unapplied advances at December 31, 2010. During 2011, Golden State converted $5,400 of the $100,000 debenture into 38,615,468 shares of common stock, exercised warrants to purchase 54,000 shares of common stock at $10.90 per share and applied $3,382 of accrued interest and advanced $750,000 against future exercises of warrants of which $588,589 was applied to the exercise of warrants leaving $164,782 of unapplied advances at June 30, 2011.

 
6

 

The Oklahoma Center for the Advancement of Science and Technology approved our application for funding of a matching grant titled 800 Million Voxels Volumetric Display, on November 19, 2008.  The two-year matching grant, totaling $299,932, had a start date of January 1, 2009.  We received approval for our no cost extension request for the first year of the contract. With the first modification, the first year ended on August 31, 2010.  The award is for a maximum of $149,940 for 2009 and the remainder for 2011.  The Company earned $54,889 and $28,765 from the grant during the six month periods ended June 30, 2011 and 2010, and $186,390 from inception to date.  We received approval for our no cost extension request for the second year of the contract. With the new modification, the second year ends on August 31, 2011.

  On October 31, 2008 OU agreed to revise the payment terms under the SRA from a fixed monthly payment to a reimbursable cost payment basis effective September 1, 2008. As of September 30, 2008 the Company had a remaining obligation under the previous SRA payment schedule of $2,665,818 which included monthly payments due for December 2007 through August 31, 2008 of $861,131. The $1,804,687 balance of the remaining scheduled payment obligation was cancelled. Under the terms of the revised base payments schedule, the arrearages would be paid in nine monthly base installments from October 31, 2008 to June 30, 2009 of amounts ranging from $35,000 to $101,132 leaving a remaining balance after the base payments of $290,000. In addition to the monthly base payments, the Company agreed to make additional payments on the $861,131 arrearages based on a formula of 50% of funding in excess of $120,000 plus the base monthly payment. In the event funding did not provide for any additional payments, the remaining balance would be $290,000, which OU agreed to accept 4,264,707 shares of the Company's common stock based on the October 14, 2008 market price as reported on the OTC Bulletin Board of $0.068 per share as payment on June 30, 2009. The Company had the option to repurchase the shares at $0.068 per share by September 30, 2009 or at market value, but not less than $0.068 per share, if the repurchase occurred after September 30, 2009.

The Company was unable to meet the revised payment schedule and on May 18, 2009 the University agreed to revise the payment terms. Under the terms of the revised base payments schedule, the arrearages scheduled to be paid in nine monthly base installments from October 31, 2008 to June 30, 2009 of amounts ranging from $35,000 to $101,132 were deferred to a monthly payment schedule of July 2009 through February 2010. On February 19, 2010, the University agreed to modify the repayment plan to retire the outstanding debt of $525,481. Under the terms of the modified repayment plan the Company agreed to make payments to the University, not less than quarterly, in an amount equal to 22.5% of any funding received by the Company. The Company complied with the agreed upon payment schedule and on December 1, 2010 the Company entered into an agreement with OU pursuant to which OU agreed to convert all sums due to it from the Company in connection with its SRA with the Company, which as of December 1, 2010 amounted to approximately $485,000, into an aggregate of 59,000,000 shares of the Company's common stock. As a result of the debt conversion, OU became the holder of approximately 8% of the outstanding common stock of the Company. Pursuant to the agreement, the shares are subject to a put option allowing OU to require the Company to purchase certain of the shares upon the occurrence of certain events. In addition, the shares are subject to a call option allowing the Company to require OU to sell to the Company the shares then held by OU in accordance with the terms of the agreement.

Off Balance Sheet Arrangements

The Company does not engage in any off balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenues, and results of operations, liquidity or capital expenditures.

Significant Accounting Policies

Research and Development Costs

The Company expenses all research and development costs as incurred. Until we have developed a commercial product, all costs incurred in connection with the SRA with the University, as well as all other research and development costs incurred, will be expensed as incurred. After a commercial product has been developed, we will report costs incurred in producing products for sale as assets, but we will continue to expense costs incurred for further product research and development activities.

Stock-Based Compensation

Since its inception 3DIcon has used its common stock or warrants to purchase its common stock as a means of compensating our employees and consultants. Financial Accounting Standards Board ("FASB") guidance on accounting for share based payments requires us to estimate the value of securities used for compensation and to charge such amounts to expense over the periods benefited.

The estimated fair value at date of grant of options for our common stock is estimated using the Black-Scholes option pricing model, as follows:

 
7

 

The expected dividend yield is based on the average annual dividend yield as of the grant date. Expected volatility is based on the historical volatility of our stock. The risk-free interest rate is based on the U.S. Treasury Constant Maturity rates as of the grant date. The expected life of the option is based on historical exercise behavior and expected future experience.

Subsequent Events

Debentures payable

In accordance with the terms of the Second Debenture an event of default occurs if the common stock of the Company trades at a price per share of $0.21 or lower. The trading price was at $0.21 or lower on several occasions during the period ended June 30, 2011 and subsequent to June 30, 2011.  On each of the occasions Golden State, by letter agreements, agreed that the occasions did not constitute a default and thereby waived the default provision for the occasions.

Common stock issued for services and liabilities

Subsequent to June 30, 2011 shares of common stock totaling 5,262,115 were issued for consulting services for which the Company recognized $48,265 of expense. Shares totaling 5,262,115 were issued to consultant for previous services provided to the Company for which the accounts payable liability was reduced by $48,265.
 
Item 3.   Quantitative and Qualitative Disclosures About Market Risk.

 Not Applicable.

Item 4.   Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act") as of the end of the period covered by this report. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective such that the information required to be disclosed by us in reports filed under the Securities Exchange Act of 1934 is (i) recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms and (ii) accumulated and communicated to our management to allow timely decisions regarding disclosure. A controls system cannot provide absolute assurance, however, that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.

Changes in Internal Control Over Financial Reporting.   During the most recent quarter ended June 30, 2011, there has been no change in our internal control over  financial  reporting  (as defined in Rule  13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected,  or is reasonably likely to materially affect, our internal control over financial reporting.

PART II

Item 1.   Legal Proceedings.

We are not a party to any pending legal proceeding, nor is our property the subject of a pending legal proceeding, that is not in the ordinary course of business or otherwise material to the financial condition of our business. None of our directors, officers or affiliates is involved in a proceeding adverse to our business or has a material interest adverse to our business.

Item 1A. Risk Factors.

Not Applicable.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.
 
Shares totaling 57,000,000, which are restricted under SEC Section 144, were issued in the first quarter of 2011 in payment of accrued salaries and payroll taxes totaling $460,405 due Martin Keating, Chairman of the Board of Directors, Hakki Refai, Chief Technology Officer and Judith Keating the Secretary of the Company.

 
8

 
 
On April 30, 2011, Newton, O'Connor, Turner & Ketchum agreed to convert their 13% convertible debentures and accrued interest, which totaled in the aggregate, $159,842 into 18,972,186 common shares of the Company’s common stock, at an average price per share of $0.008, under the terms of the convertible debentures. Additionally, 200,000 shares of common stock were issued in consideration of extending the due dates of the notes from September 30, 2010 to April 30, 2011.  The shares are restricted under SEC Section 144.
 
During the second quarter of 2011, various individuals converted $400,877 of 5% Promissory Notes and accrued interest of $9,020 into 163,631,653 shares of common stock at $0.0025 per share.  The shares are restricted under SEC Section 144.
 
During the three-month periods ended June 30, 2011 shares of common stock totaling 3,200,000 were issued for consulting services.  Additionally, during the period ending June 30, 2011 shares totaling 7,191,781 were issued to consultants for previous services provided to the Company.

The Company received $20,000 and after withholding the related income taxes, shares of common stock totaling 3,869,962 were issued upon the exercise of four million options under the terms of the employment agreement with Dr. Hakki Refai.
 
Item 3. Defaults Upon Senior Securities.

None.

Item 4. (Removed And Reserved).

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibit
Number
 
Description of Exhibit
     
31.1
 
Certification of Chief Executive Officer required by Rule 13a-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Chief Financial Officer required by Rule 13a-14 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Chief Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
9

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
 3DICON CORPORATION
 
/s/ Sidney A. Aroesty
August 12, 2011
 
Sidney A. Aroesty
   
Chief Executive Officer
     
                       /s/ Chris T. Dunstan
August 12, 2011
 
Chris T. Dunstan
    Interim Chief Financial Officer
 
 
10